{
  "url": "https://openlegislation.uk/medicines-for-human-use-prescribing-order-2005/article-7",
  "json_url": "https://openlegislation.uk/medicines-for-human-use-prescribing-order-2005/article-7.json",
  "legislation": "uksi/2005/765",
  "legislation_title": "The Medicines for Human Use (Prescribing) Order 2005",
  "legislation_url": "https://openlegislation.uk/medicines-for-human-use-prescribing-order-2005",
  "path": "article/7",
  "kind": "article",
  "number": "7",
  "heading": "Amendment of Schedule 3A to the POM Order",
  "text": "In the table in Schedule 3A to the POM Order, (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers)—\n(a) in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 below, and in column 2, insert, against that entry, the corresponding entry in column 2 below—\nColumn 1\nColumn 2\nAcetylcysteine\nParenteral\nAdrenaline\nParenteral\nAlteplase\nParenteral\nAmiodarone\nParenteral\nBemiparin sodium\nParenteral\nBenzatropine mesilate\nParenteral\nCalcipotriol\nExternal\nCalcitriol\nExternal\nCefotaxime sodium\nParenteral\nCeftriaxone Sodium\nParenteral\nCertoparin sodium\nParenteral\nChlorphenamine maleate\nParenteral\nCimetidine\nParenteral\nCyclizine hydrochloride\nOral\nCyclizine lactate\nParenteral\nDalteparin sodicum\nParenteral\nDexamethasone sodium phosphate\nOral\nDextran 70\nParenteral\nDolesetron mesilate\nOral and parenteral\nEnoxaparin\nParenteral\nFurosemide\nOral and parenteral\nGelatin 3.5 – 4%\nParenteral\nGlucose 5%\nParenteral\nGlucose 5% with Potassium (K+ 40 mmol/L) ready made infusion bag\nParenteral\nGranisetron hydrochloride\nParenteral\nHeparin sodium\nParenteral for the purpose of cannulae flushing\nHexastarch\nParenteral\nHuman soluble insulin\nParenteral\nHydroxyethl starch\nParenteral\nLevomepromazine\nOral and parenteral\nNaloxone\nParenteral\nOmeprazole\nOral\nOmeprazole sodium\nParenteral\nOndansetron Hydrochloride\nOral and parenteral\nOxbuprocaine hydrochloride\nOphalmic\nPentastarch\nParenteral\nPrilocaine\nExternal and parenteral\nProchlorperazine mesilate\nOral and rectal\nProchlorperazine maleate\nOral, rectal and buccal\nProxymetacaine hydrochloride\nOphthalmic\nReteplase\nParenteral\nSodium chloride 0.9%\nParental, for reconstitution of injections and for the purpose of cannulae flushing\nSodium chloride 0.9% & Glucose 5% ready made infusion bag\nParenteral\nSodium chloride 0.45% & Glucose 5% ready made infusion bag\nParenteral\nSodium chloride 0.9% with Potassium (K+ 40 mmol/L) ready made infusion bag\nParenteral\nSodium chloride 0.45% and Glucose 5% with Potassium 20mmol per 500 ml ready made infusion bag\nParenteral\nStreptokinase\nParenteral\nTacalcitol\nExternal\nTenecteplase\nParenteral\nTetanus immunoglobulin\nParenteral\nTetracaine\nExternal\nTinzaparin sodium\nParenteral\nTropicamide\nOphthalmic\nTropisetron hydrochloride\nParenteral\nUnfractionated Heparin\nParenteral\nVaccine – Combined Tetanus, diphtheria, acullular pertussis, inactivated poliomyelitis and haemophilus influenza type B\nParenteral\nVaccine – Inactivated Poliomyelitis\nParenteral\nVaccine – Meningococcal Polysaccharide A, C, W135 and Y\nParenteral\n(b) in the entry for “Beclometasone dipropionate”, in column 2, after “nasal” add “inhalation”;\n(c) in the entry for “Budesonide”, in column 2, after “Nasal” add “inhalation”;\n(d) omit the entry for “Cyclizine”;\n(e) in the entry for “Diazepam”, in column 2, omit “in palliative care”;\n(f) in the entry for “Diclofenac sodium”, in column 2, after “oral” omit “or” and after “rectal” add “or ophthalmic”;\n(g) in the entry for “Domperidone”, in column 2, omit “in palliative care”;\n(h) in the entry for “Domperidone maleate”, in column 2, omit “in palliative care”;\n(i) in the entry for “Flucloxacillin sodium”, in column 2, after “oral” add “or parenteral”;\n(j) in the entry for “Hydrocortisone sodium succinate”, in column 2, after “lozenges” add “or parenteral”;\n(k) in the entry for “Ipratropium bromide”, in column 2, after “nasal” add “inhalation”;\n(l) in the entry for “Lorazepam”, in column 2, omit “in palliative care”;\n(m) in the entry for “metoclopramide hydrochloride”, in column 2, omit “in palliative care”;\n(n) in the entry for “Midazolam”, in column 2, omit “in palliative care”;\n(o) in the entry for “Ranitidine hydrochloride”, in column 2, after “Oral” insert “or parenteral”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Schedule 3A was inserted by S.I. 2002/549, and amended by S.I. 2003/696 and 2915, and 2004/2, 1189 and 2693."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "The entry for “Diazepam” was inserted by S.I. 2003/2915."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "The entry for “Diclofenac Sodium” was inserted by S.I. 2004/2."
    },
    {
      "type": "footnote",
      "label": "f4",
      "text": "The entry for “Lorazepam” was inserted by S.I. 2003/2915."
    },
    {
      "type": "footnote",
      "label": "f5",
      "text": "The entry for “Midazolam” was inserted by S.I. 2003/2915."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/765/article/7",
    "retrieved_at": "2026-10-29T05:03:14.406634+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}